Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells

J Neuropathol Exp Neurol. 1995 Sep;54(5):651-6. doi: 10.1097/00005072-199509000-00006.

Abstract

Gliosarcomas are morphologically heterogeneous tumors of the central nervous system composed of gliomatous and sarcomatous components. The histogenesis of the latter is still a matter of debate. As mutations of the p53 tumor suppressor gene represent an early event in the development of gliomas, we attempted to determine whether both components of gliosarcomas share identical alterations of the p53 gene. Using single-strand conformation analysis (SSCA) and direct DNA sequencing of the p53 gene, we analyzed dissected gliomatous and sarcomatous parts of 12 formalin-fixed, paraffin-embedded gliosarcomas. The two tumors that contained a p53 alteration were found to carry the identical mutation (exon 5; codon 151, CCC-->TCC; codon 173, GTG-->GTA) in the gliomatous and the sarcomatous components. These findings suggest a common origin of the two cellular components from neoplastic glial cells.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Base Sequence
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / pathology
  • Central Nervous System Neoplasms / genetics*
  • Central Nervous System Neoplasms / pathology
  • Child
  • Codon
  • Exons
  • Female
  • Genes, p53*
  • Glioma / genetics
  • Glioma / pathology
  • Gliosarcoma / genetics*
  • Gliosarcoma / pathology
  • Humans
  • Male
  • Middle Aged
  • Neuroglia / cytology
  • Neuroglia / pathology*
  • Point Mutation*
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Sarcoma / genetics
  • Sarcoma / pathology

Substances

  • Codon